4.1 Article

COVID-19-Induced Sporadic Inclusion Body Myositis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Assessment and characterisation of post-COVID-19 manifestations

Marwa Kamal et al.

Summary: The study found that the majority of COVID-19 survivors experience post-viral symptoms, with fatigue being the most common, and some experiencing severe complications such as stroke and myocarditis. The presence of comorbidities prior to COVID-19 infection is related to the severity of post-COVID-19 manifestations.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Article Endocrinology & Metabolism

Long COVID: An overview

A. V. Raveendran et al.

Summary: Long COVID refers to the persistence of symptoms in individuals who have recovered from SARS-CoV-2 infection, possibly related to organ damage, post viral syndrome, etc. Clinical evaluation should focus on identifying the pathophysiology and appropriate remedial measures.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Article Biotechnology & Applied Microbiology

Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis

Leonardo Valente de Camargo et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Article Clinical Neurology

Treatment of sporadic inclusion body myositis with bimagrumab

Anthony A. Amato et al.

NEUROLOGY (2014)

Article Clinical Neurology

Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis

Merrilee Needham et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2008)

Review Clinical Neurology

Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies

Marinos C. Dalakas

NATURE CLINICAL PRACTICE NEUROLOGY (2006)